{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:00:48Z","timestamp":1783702848605,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.2119\/molmed.2016.00110","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T06:06:19Z","timestamp":1506751579000},"page":"204-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tolerogenic Dendritic Cells Induced by BD750 Ameliorate Proinflammatory T cell Responses and Experimental Autoimmune Encephalitis in Mice"],"prefix":"10.1186","volume":"23","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"key":"2301204_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMct1101691","volume":"366","author":"D Pelletier","year":"2012","unstructured":"Pelletier D, Hafler DA. (2012) Fingolimod for multiple sclerosis. New Engl. J. Med. 366:339\u201347.","journal-title":"New Engl. J. Med."},{"key":"2301204_CR2","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. (2008) Multiple sclerosis. Lancet. 372:1502\u201317.","journal-title":"Lancet"},{"key":"2301204_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exper. Med. 199:971\u20139.","journal-title":"J. Exper. Med."},{"key":"2301204_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/eji.201242402","volume":"42","author":"CC Gross","year":"2012","unstructured":"Gross CC, Jonuleit H, Wiendl H. (2012) Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis. Eur. J. Immunol. 42:569\u201372.","journal-title":"Eur. J. Immunol."},{"key":"2301204_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","volume":"30","author":"RM Steinman","year":"2012","unstructured":"Steinman RM. (2012) Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30:1\u201322.","journal-title":"Annu. Rev. Immunol."},{"key":"2301204_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","volume":"21","author":"RM Steinman","year":"2003","unstructured":"Steinman RM, Hawiger D, Nussenzweig MC. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685\u2013711.","journal-title":"Annu. Rev. Immunol."},{"key":"2301204_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.autrev.2010.07.015","volume":"10","author":"H Torres-Aguilar","year":"2010","unstructured":"Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y. (2010) Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun. Rev. 10:8\u201317.","journal-title":"Autoimmun. Rev."},{"key":"2301204_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrrheum.2010.184","volume":"6","author":"S Price","year":"2010","unstructured":"Price S. (2010) Therapeutic effects of tolerogenic dendritic cells. Nat. Rev. Rheumatol. 6:674.","journal-title":"Nat. Rev. Rheumatol."},{"key":"2301204_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clim.2013.04.017","volume":"148","author":"C Llanos","year":"2013","unstructured":"Llanos C, Mackern-Oberti JP, Vega F, Jacobelli SH, Kalergis AM. (2013) Tolerogenic dendritic cells as a therapy for treating lupus. J. Clin. Immunol. 148:237\u201345.","journal-title":"J. Clin. Immunol."},{"key":"2301204_CR10","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1002\/art.27756","volume":"62","author":"JN Stoop","year":"2010","unstructured":"Stoop JN, et al. (2010) Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum. 62:3656\u201365.","journal-title":"Arthritis Rheum."},{"key":"2301204_CR11","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.4049\/jimmunol.178.12.7849","volume":"178","author":"HK Kang","year":"2007","unstructured":"Kang HK, Liu M, Datta SK. (2007) Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J. Immunol. 178:7849\u201358.","journal-title":"J. Immunol."},{"key":"2301204_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/cns.12071","volume":"19","author":"AS Farias","year":"2013","unstructured":"Farias AS, et al. (2013) Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci. Ther. 19:269\u201377.","journal-title":"CNS Neurosci. Ther."},{"key":"2301204_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/eji.201141835","volume":"42","author":"D Raiotach-Regue","year":"2012","unstructured":"Raiotach-Regue D, et al. (2012) Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur. J. Immunol. 42:771\u201382.","journal-title":"Eur. J. Immunol."},{"key":"2301204_CR14","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.4049\/jimmunol.1203053","volume":"191","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T, et al. (2013) Protein kinase C inhibitor generates stable human tolerogenic dendritic cells. J. Immunol. 191:2247\u201357.","journal-title":"J. Immunol."},{"key":"2301204_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1476-5381.2012.02172.x","volume":"168","author":"Y Liu","year":"2013","unstructured":"Liu Y, et al. (2013) BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3\/STAT5 signalling pathway. Brit. J. Pharmacol. 168:632\u201343.","journal-title":"Brit. J. Pharmacol."},{"key":"2301204_CR16","doi-asserted-by":"publisher","first-page":"e7066","DOI":"10.1371\/journal.pone.0007066","volume":"4","author":"A Rivas-Caicedo","year":"2009","unstructured":"Rivas-Caicedo A, et al. (2009) Jak3 is involved in dendritic cell maturation and CCR7-dependent migration. PLoS One 4:e7066.","journal-title":"PLoS One"},{"key":"2301204_CR17","first-page":"5021537","volume":"2016","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, et al. (2016) Tolerogenic dendritic cells generated with tofacitinib ameliorate experimental autoimmune encephalomyelitis through modulation of Th17\/Treg balance. J. Immunol. Res. 2016:5021537.","journal-title":"J. Immunol. Res."},{"key":"2301204_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ni.2541","volume":"14","author":"BD Bell","year":"2013","unstructured":"Bell BD, et al. (2013) The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses. Nat. Immunol. 14:364\u201371.","journal-title":"Nat. Immunol."},{"key":"2301204_CR19","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/nprot.2006.285","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes IM, Goverman JM. (2006) Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1:1810\u201319.","journal-title":"Nat. Protoc."},{"key":"2301204_CR20","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba K, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J. Exper. Med. 176:1693\u2013702.","journal-title":"J. Exper. Med."},{"key":"2301204_CR21","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1182\/blood-2002-01-0260","volume":"100","author":"Y Yanagawa","year":"2002","unstructured":"Yanagawa Y, Onoe K. (2002) CCL19 induces rapid dendritic extension of murine dendritic cells. Blood. 100:1948\u201356.","journal-title":"Blood"},{"key":"2301204_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1084\/jem.192.3.405","volume":"192","author":"H Tanaka","year":"2000","unstructured":"Tanaka H, Demeure CE, Rubio M, Delespesse G, Sarfati M. (2000) Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1\/Th2 effectors. Role of stimulator\/responder ratio. J. Exper. Med. 192:405\u201312.","journal-title":"J. Exper. Med."},{"key":"2301204_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","volume":"38","author":"E Segura","year":"2013","unstructured":"Segura E, et al. (2013) Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity. 38:336\u201348.","journal-title":"Immunity"},{"key":"2301204_CR24","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1136\/ard.2009.126383","volume":"69","author":"RA Harry","year":"2010","unstructured":"Harry RA, Anderson AE, Isaacs JD, Hilkens CM. (2010) Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann. Rheum. Dis. 69:2042\u201350.","journal-title":"Ann. Rheum. Dis."},{"key":"2301204_CR25","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.1102346","volume":"188","author":"Y Sonobe","year":"2012","unstructured":"Sonobe Y, et al. (2012) Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells. J. Immunol. 188:2602\u201311.","journal-title":"J. Immunol."},{"key":"2301204_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cns.12342","volume":"21","author":"MJ Mansilla","year":"2015","unstructured":"Mansilla MJ, et al. (2015) Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis. CNS Neurosci. Therap. 21:222\u201330.","journal-title":"CNS Neurosci. Therap."},{"key":"2301204_CR27","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.4049\/jimmunol.1003977","volume":"186","author":"L Laar van de","year":"2011","unstructured":"van de Laar L, et al. (2011) Tight control of STAT5 activity determines human CD34-derived interstitial dendritic cell and langerhans cell development. J. Immunol. 186:7016\u201324.","journal-title":"J. Immunol."},{"key":"2301204_CR28","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4049\/jimmunol.1401635","volume":"194","author":"PA Toniolo","year":"2015","unstructured":"Toniolo PA, et al. (2015) Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation. J. Immunol. 194:3180\u201390.","journal-title":"J. Immunol."},{"key":"2301204_CR29","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.2337\/dc11-0472","volume":"34","author":"N Giannoukakis","year":"2011","unstructured":"Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M. (2011) Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care. 34:2026\u201332.","journal-title":"Diabetes Care"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2016.00110\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.molmed.org\/content\/pdfstore\/16_110_Zhou.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T01:40:58Z","timestamp":1554514858000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2016.00110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2301204"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2016.00110","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"23 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}